BCL11A and Schnyder corneal dystrophy: In addition, a Cas9:sgRNA RNP complex was constructed to target the BCL11A binding motif in the γ‐globin gene promoter in HSPCs, abolishing the BCL11A binding site and increasing the HbF level to a therapeutic level, which is a highly specific and safe treatment strategy for SCD.244